Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMI trial of prednisolone in early pregnancy for unexplained recurrent miscarriage
NL-OMON60154Phase 4Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in recurrent miscarriage (RPL) comparing Prednisolone with Placebo (2 arms). Primary endpoints: Live birth rate and Study completion milestone. Started Feb 2024; status: recruiting.
02
Drugs
prednisolone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NL-OMON60154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60154.